Clinical Decision Support
PMcardio Queen of Hearts vs VisualDx
Scores are legacy evidence and documentation scores, not product-performance ratings. How it is computed
PMcardio Queen of Hearts scores 59 of 100 (Solid choice), VisualDx 30 (Competitive). PMcardio Queen of Hearts starts at EUR 10 per user per month, VisualDx at $249.99 per year.
Decision support · Reviewed November 5, 2026
On this page
PMcardio Queen of Hearts
by Powerful Medical · founded 2017
FDA De Novo authorized AI ECG model that flags STEMI and STEMI-equivalent occlusion MI on any 12-lead ECG, in the PMcardio app and in health-system STEMI pathways.
VisualDx
by VisualDx · founded 1999
Differential diagnosis builder with 50,000+ clinical images across skin tones and body sites.
Score
Each row shows points earned of points available under the published rubric.
PMcardio Queen of Hearts
VisualDx
| Dimension | PMcardio Queen of Hearts | VisualDx | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 8.4 / 21 | 0 |
| RCT / meta-analysis / systematic review | 4.5 / 9 | 0 / 9 | +4.5 |
| Funding & adoption signal | 6 / 12 | 8.4 / 12 | -2.4 |
| Pricing transparency | 2.5 / 2.5 | 2.5 / 2.5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
PMcardio Queen of Hearts
| Tier | Billing period | Price | Notes |
|---|---|---|---|
| Free | per month | Free | 5 ECG reports per month, no credit card. The pricing page defaults to the Slovak region and says prices vary by country. |
| Individuals | per user per month | EUR 10 | 10 EUR per month, 17 percent off billed yearly. 50 ECGs per month, Queen of Hearts, LVsense, ECGxplain and 36 core diagnostics, mobile app only, 30-day report history. Paid through the app store. Slovak-region price; the page says prices vary by country. |
| Teams | per year | EUR 2,610 | 2,610 EUR per year for 10 users (22 EUR per user per month, billed yearly), scalable to 50 users, 1,000 ECGs per month, web app, unlimited report history, US or EU data centre, onboarding session. Invoiced. Slovak-region price. |
| Organizations | Not stated | Not stated | No public price. Unlimited reports, users and locations, HL7/XML and EHR integration, AI-powered STEMI pathway, dedicated data residency and SLA. Contact sales. |
Verified November 5, 2026 from powerfulmedical.com (opens in new tab).
VisualDx
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Core (education) | Not stated | $249.99 | Shown as $39.99 or $20.83 per month, billed annually. Free trial length is not stated. Annual plans that auto-renew have a 30-day grace period for a full refund of the renewed fee. |
| Elite (clinicians) | Not stated | $299.99 | Shown as $49.99 or $24.99 per month, billed annually. |
| Groups and Enterprise | Not stated | Not stated | Contact for pricing, including small groups of 2 to 5 users. |
Evidence
PMcardio Queen of Hearts
FDA decisions
DEN250044 (opens in new tab)De Novo2026-09-03
STEMI AI ECG Model
Peer-reviewed
6 PubMed records name PMcardio Queen of Hearts.
- Electrocardiographic diagnostic possibilities for atrial fibrillation using artificial intelligence: Differentiation from sinus rhythm and other arrhythmias with the PMcardio app in COVID-19 patients. (opens in new tab)
- Bifascicular Block Associated With Myocardial Infarction: A Marker of Proximal Left Anterior Descending Artery Occlusion Confirmed by the Artificial Intelligence-Based Smartphone App Queen of Hearts. (opens in new tab)
- Accuracy of cath lab activation decisions for STEMI-equivalent and mimic ECGs: Physicians vs. AI (Queen of Hearts by PMcardio). (opens in new tab)
VisualDx
FDA decisions
No FDA decision cited in our research as of November 8, 2026.
Peer-reviewed
4 PubMed records name VisualDx.
- Early Perspectives on Utilization of a Clinical Decision Support Tool: A Mixed-Methods Study. (opens in new tab)
- Experiences, challenges and lessons while implementing a clinical decision support system in Botswana. (opens in new tab)
- Racial disparities in skin tone representation of dermatomyositis rashes: a systematic review. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | PMcardio Queen of Hearts | VisualDx |
|---|---|---|
| Free tier | Yes | Yes |
| HIPAA | Yes | No / unverified |
| SOC 2 Type II | Yes | No / unverified |
| EHR integrations | Not stated | Not stated |
| Founded | 2017 | 1999 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.
See all decision support